⌘K

Home/Filings/4/0001144204-17-051254

4//SEC Filing

CAPITELLI SARA B 4

Accession 0001144204-17-051254

CIK 0000895051other

View on SEC.gov Company Profile

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 6:51 PM ET

Size

5.5 KB

Accession

0001144204-17-051254

Insider Transaction Report

Form 4

Period: 2017-09-29

CASI Pharmaceuticals, Inc.CASI

CAPITELLI SARA B

VP, Finance and PAO

Transactions

Award
Stock Options (Right to Buy)
2017-09-29+20,000→ 20,000 total
Exercise: $1.99Exp: 2022-08-15→ Common Stock (20,000 underlying)

Footnotes (1)

[F1]On August 15, 2012, the reporting person was granted an option to purchase 20,000 shares of common stock, which vested upon the achievement of a performance condition on September 29, 2017.

Documents

1 file

4
v476425_4.xmlPrimary
FORM 4

Issuer

CASI Pharmaceuticals, Inc.

CIK 0000895051

Entity typeother

Related Parties

1

filerCIK 0001509032

Filing Metadata

Form type: 4
Filed: Oct 2, 8:00 PM ET
Accepted: Oct 3, 6:51 PM ET
Size: 5.5 KB

View on SEC.gov